Bayesian Capital Management’s Usana Health Sciences USNA Stock Holding History

Bayesian Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,970	Closed	-$365K	–	705
2020 Q2	$365K	Sell	4,970 -1,242	-20%	-$97.4K	0.08%	309
2020 Q1	$359K	Buy	+6,212	New	+$432K	0.08%	389
2019 Q1	–	Sell	-7,304	Closed	-$860K	–	764
2018 Q4	$860K	Sell	7,304 -4,000	-35%	-$463K	0.18%	186
2018 Q3	$1.36M	Buy	11,304 +5,900	+109%	+$732K	0.22%	119
2018 Q2	$623K	Buy	+5,404	New	+$591K	0.14%	214

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bayesian Capital Management's USNA Position: Q3 2020 in Review

Bayesian Capital Management sold out of Usana Health Sciences (USNA) in Q3 2020, closing a stake of 4,970 shares — an estimated $365K sold.

Bayesian Capital Management first reported a position in USNA in Q2 2018 and held it in 5 quarters. The position peaked at $1.36M in Q3 2018. 192 funds tracked by Wall St. Rank hold USNA as of Q3 2020.

Bayesian Capital Management reported no remaining Usana Health Sciences position as of Q3 2020 after selling out during the quarter.
Bayesian Capital Management sold 4,970 Usana Health Sciences shares in Q3 2020, an estimated $365K.
Bayesian Capital Management first reported a position in Usana Health Sciences in Q2 2018 and held it in 5 quarters.
Bayesian Capital Management's Usana Health Sciences position peaked at $1.36M in Q3 2018.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2020.

Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.